Skip to main content
. 2023 Apr 24;10:1161268. doi: 10.3389/fmed.2023.1161268

Table 3.

Comparison of evaluated assay and standard WHO/GIRS assays currently used in the laboratory.

Sensitivity Specificity Positive predictive value Negative predictive value Overall percent agreement
SARS-CoV-2 GX 96.6 (88.3–99.6) 100.0 (93.7–100.0) 100.0 (97.8–100.0) 98.8 (95.7–99.9) 99.1 (97.0–99.9)
TP 96.6 (88.3–99.6) 100.0 (98.0–100.0) 100.0 (93.7–100.0) 98.9 (96.0–99.9) 99.2 (97.0–99.9)
PC 95.0 (85.9–98.9) 99.4 (96.9–100.0) 98.2 (90.6–100.0) 98.4 (95.3–99.7) 98.3 (95.8–99.5)
Influenza A virus GX 100.0 (93.3–100.0) 100.0 (98.0–100.0) 100 (93.3–100.0) 100.0 (98.0–100.0) 100.0 (98.4–100.0)
PC 100.0 (95.7–100.0) 99.4 (96.9–100.0) 98.8 (93.6–100.0) 100.0 (98.1–100.0) 99.6 (98.0–100.0)
Influenza B virus GX 100.0 (47.8–100.0) 100 (98.2–100.0) 100.0 (47.8–100.0) 100.0 (98.2–100.0) 100.0 (98.2–100.0)
PC 100.0 (47.8–100.0) 98.6 (96.1–99.7) 62.5 (24.5–91.5) 100.0 (98.3–100.0) 98.7 (96.2–99.7)
InfluenzaA/B TPa 100.0 (96.0–100.0) 100.0 (98.0–100.0) 100.0 (97.9–100.0) 100.0 (97.9–100.0) 100.0 (98.6–100.0)
Respiratory syncytial virus GX 87.5 (71.0–96.5) 100.0 (97.8–100.0) 100.0 (87.7–100.0) 97.6 (94.0–99.3) 97.9 (94.8–99.4)
TP 96.9 (83.8–99.9) 100.0 (97.9–100.0) 100.0 (88.8–100.0) 99.4 (96.9–100.0) 99.5 (97.4–100.0)
PC 100.0 (89.1–100.0) 99.4 (96.9–100.0) 97.0 (84.2–99.9) 100.0 (97.9–100.0) 99.5 (97.4–100.0)

SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; GX, Xpert® Xpress SARS-CoV-2, Flu, RSV Kit; TP, TaqPath™ COVID-19, FluA/B, RSV Combo Kit; PC, PowerChek™ SARS-CoV-2, Influenza A&B, RSV Multiplex Real-time PCR Kit II; FAO, Food and Agriculture Organization of United Nations recommended primers and probes developed by the Australian Center for Disease Prevention for the detection of M gene from avian influenza.

a

TP provides a combined influenza result for IAV and IBV as targets are combined in the same optical detection channel. Therefore, IAV and IBV results were combined for statistical tests.